1. Home
  2. PRME

as 10-07-2025 9:55am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Founded: 2019 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 693.5M IPO Year: 2022
Target Price: $8.88 AVG Volume (30 days): 3.8M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.57 EPS Growth: N/A
52 Week Low/High: $1.11 - $6.94 Next Earning Date: 11-11-2025
Revenue: $4,961,000 Revenue Growth: 739.42%
Revenue Growth (this year): 179.58% Revenue Growth (next year): -64.06%

PRME Daily Stock ML Predictions

Share on Social Networks: